chr11-68325869-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002335.4(LRP5):c.91+13064C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 152,232 control chromosomes in the GnomAD database, including 1,163 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1163 hom., cov: 33)
Consequence
LRP5
NM_002335.4 intron
NM_002335.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0500
Publications
7 publications found
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
- bone mineral density quantitative trait locus 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- exudative vitreoretinopathy 4Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- inherited retinal dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- osteoporosis-pseudoglioma syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal dominant osteosclerosis, Worth typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- polycystic liver disease 4 with or without kidney cystsInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal dominant osteopetrosis 1Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- exudative vitreoretinopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyperostosis corticalis generalisataInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- osteosclerosis-developmental delay-craniosynostosis syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polycystic liver disease 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.114 AC: 17305AN: 152114Hom.: 1161 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
17305
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.114 AC: 17320AN: 152232Hom.: 1163 Cov.: 33 AF XY: 0.110 AC XY: 8180AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
17320
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
8180
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
7819
AN:
41522
American (AMR)
AF:
AC:
1526
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
174
AN:
3472
East Asian (EAS)
AF:
AC:
457
AN:
5176
South Asian (SAS)
AF:
AC:
189
AN:
4830
European-Finnish (FIN)
AF:
AC:
351
AN:
10616
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6320
AN:
68002
Other (OTH)
AF:
AC:
230
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
784
1568
2351
3135
3919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.